Hello Paul
Sorry to hear about the poor weather in Sydney. We're enjoying a typically
bonzer English summer. 37 degrees! We've never known the like although I
recollect that when I visited your lovely city you considered this temp.
slightly cool.
Anyway, I'll be grateful for a copy of your stuff too. Needless to say I'll
be happy to reciprocate.
All the best
Bill
-----Original Message-----
From: A group for the academic discussion of current issues in podiatry
[mailto:[log in to unmask]] On Behalf Of Paul Conneely
Sent: 18 July 2006 10:06
To: [log in to unmask]
Subject: Re: Use of LA for treatment of chronic plantar fasciitis
Dear Mark
Paul Conneely here in wet Sydney.
I have started a new approach to this problem. Currently we are recruiting
500 patients with PF. Diagnosis using U/S and or CT. We are measuring not
only thickness but surface areas.
There is several different questionaires depending on what we find.
I would like to get hold of all your information (statistics ets.) so that
we can put this before the review committee regarding the ethics etc. as we
are going to trial mixed treatments as well as sham.
I am compiling some extremely new information re PF and I will send you a
copy when I complete the first efforts this week. The results so far are
astounding to say the least.
Regards
Paul Conneely
www.musmed.com.au
Quoting Mark Gallagher <[log in to unmask]>:
> Hi Mandy, I completed a very similar study to Bill's in regard to the
> use of LA as a therapeutic tool for plantar fascial pain. My Thesis
> was titled Is bupivaciane hydrochloride 0.5% a useful adjunct to a
> tibial block in the treatment of plantar heel pain? Essentially it was
> looking at the effect of using the serial nerve blocks used in Bills
> study and trying to assess its impact. I therefore has two groups with
> the experimential group (n20) receiving a Bupivaciane infiltration
> into the heel and the control group (n20) receiving saline into the heel.
>
>
>
> Both these groups improved at 6 week 12 week and 12 month follow up
> with the Bupivacaine group having a statistically significant greater
> improvement.
>
>
>
> One of the main side issue outcomes of the study was to provide a
> treatment process that allowed a more used friendly injection
> technique of plantar fascial injections.
>
>
>
> Let me know if you need any more info.
>
>
>
> Regards
>
>
>
> Mark Gallagher
>
>
>
> Department of Podiatry
>
> University Hospital Birmingham NHS Trust
>
>
>
> -----Original Message-----
> From: A group for the academic discussion of current issues in
> podiatry [mailto:[log in to unmask]] On Behalf Of Mandy Abbott
> Sent: 11 July 2006 17:14
> To: [log in to unmask]
> Subject: Use of LA for treatment of chronic plantar fasciitis
>
>
>
> Hi all,
>
>
>
> I was wanting to know if anyone out there was using LA in the
> treatment of chronic, or acute plantar fasciitis and can advise on
> it's success rate? Also does anyone know of any further research
> and/or evidence for this treatment method?
>
>
>
> The only evidence I can find is:
>
> Liggins, WJ and Pavier, JCS. The use of 0.5% Bupivicaine
> hydrochloride in the treatment of chronic plantar fasciitis. British
> Jouranl of Podiatry. 2001;4(3):90-94.
>
>
>
> Kind regards
>
>
>
> Mandy
>
>
>
> ________________________________
>
> All new Yahoo! Mail
> <http://us.rd.yahoo.com/mail/uk/taglines/default/nowyoucan/pc_mag/*http:
> /us.rd.yahoo.com/evt=40565/*http:/uk.docs.yahoo.com/nowyoucan.html>
> "The new Interface is stunning in its simplicity and ease of use." -
> PC Magazine
> ----------------------------------------------------------------- This
> message was distributed by the Podiatry JISCmail list server All
> opinions and assertions contained in this message are those of the
> original author. The listowner(s) and the JISCmail service take no
> responsibility for the content. to leave the Podiatry email list send
> a message containing the text leave podiatry to
> [log in to unmask] Please visit http://www.jiscmail.ac.uk for any
> further information
> -----------------------------------------------------------------
>
>
> DISCLAIMER:
> This e-mail and any attachments hereto contains proprietary
> information, some or all of which may be confidential or legally
> privileged. It is for the exclusive use of the intended recipient(s)
> only. If an addressing or transmission error has misdirected this
> e-mail and you are not the intended recipient(s), please notify the
> author by replying to this e-mail. If you are not the intended
> recipient you must not use, disclose, distribute, copy, print, or rely
> on this e-mail or any attachments, as this may be unlawful.
>
> -----------------------------------------------------------------
> This message was distributed by the Podiatry JISCmail list server All
> opinions and assertions contained in this message are those of the
> original author. The listowner(s) and the JISCmail service take no
> responsibility for the content.
> to leave the Podiatry email list send a message containing the text
> leave podiatry to [log in to unmask] Please visit
> http://www.jiscmail.ac.uk for any further information
> -----------------------------------------------------------------
>
----------------------------------------------------------------
This message was sent using IMP, the Internet Messaging Program.
-----------------------------------------------------------------
This message was distributed by the Podiatry JISCmail list server All
opinions and assertions contained in this message are those of the original
author. The listowner(s) and the JISCmail service take no responsibility for
the content.
to leave the Podiatry email list send a message containing the text leave
podiatry to [log in to unmask] Please visit http://www.jiscmail.ac.uk
for any further information
-----------------------------------------------------------------
-----------------------------------------------------------------
This message was distributed by the Podiatry JISCmail list server
All opinions and assertions contained in this message are those of
the original author. The listowner(s) and the JISCmail service take
no responsibility for the content.
to leave the Podiatry email list send a message containing the text
leave podiatry
to [log in to unmask]
Please visit http://www.jiscmail.ac.uk for any further information
-----------------------------------------------------------------
|
